Andere Sprachen Landos Biopharma, Inc.

Aktien

A3EFBP

US5150692011

LABP

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 30.04.2024			% 5 Tage	% 1. Jan.
22,3 ^USD	-0,80 %		+0,68 %	+509,29 %

01.04.	LANDOS BIOPHARMA, INC. : Vom Kauf zur neutralen Bewertung von HC Wainwright	ZM
25.03.	Deals des Tages - Fusionen und Übernahmen	RE

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie	16.04.
North American Morning Briefing : Stocks Seen -2-	02.04.
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP	27.03.
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABP	27.03.
Deals of the day-Mergers and acquisitions	25.03.
Sector Update: Health Care Stocks Decline Late Afternoon	25.03.
INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE	25.03.
Top Midday Gainers	25.03.
Sector Update: Health Care Stocks Softer in Afternoon Trading	25.03.
Shareholder Alert: Ademi LLP investigates whether Landos Biopharma, Inc. has obtained a Fair Price in its transaction with AbbVie	25.03.
LABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholders	25.03.
AbbVie to Acquire Landos Biopharma For About $137.5 Million; Landos Shares Jump	25.03.
Landos Biopharma Shares Surge 178% on Takeover Deal With AbbVie	25.03.
AbbVie in Deal to Acquire Landos Biopharma for $137.5 Million	25.03.
AbbVie to Acquire Landos Biopharma for About $137.5 Million	25.03.
AbbVie to Acquire Landos Biopharma for About $137.5 Million	25.03.
AbbVie to buy Landos to expand pipeline of immunity-related illnesses	25.03.
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases	25.03.
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases	25.03.
AbbVie Inc. agreed to acquire Landos Biopharma, Inc. on March 24, 2024.	25.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Landos Biopharma, Inc.

Aktien

A3EFBP

US5150692011

LABP

Andere Sprachen

Filter